课题基金 / 基金详情

A new chemotherapeutic target from Leishmania SPP. Understanding and inhibiting CYP61LD, a sterol C22 desaturase

A new chemotherapeutic target from Leishmania SPP. Understanding and inhibiting CYP61LD, a sterol C22 desaturase
利什曼原虫 SPP 的新化疗靶点。
批准号:
DP110104455
负责人:
Prof James De Voss
金额:
$19.65万
依托单位国家:
澳大利亚
项目类别:
Discovery Projects
财政年份:
2011
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2011-01-01 至 2013-12-31

项目摘要

项目成果

Prof James De Voss的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
Leishamniasis is a debilitating and often fatal disease that is caused by a parasite, Leishmania sp., which is increasing its range to include Australia. This project aims to explore possible chemotherapeutics for the disease which inhibit a particular and unique enzyme the organism uses to synthesise the sterols it requires to live.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Mycobacterial Cholesterol Degradation: A Unique Metabolic Weakness?
  • 批准号:
    DP210103970
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $35.02万
  • 财政年份:
    2021
  • 负责人:
    Prof James De Voss
  • 依托单位:
Bioproduction and bioavailability of steroidal saponins, bioactives in herbal medicines
  • 批准号:
    LP140100958
  • 项目类别:
    Linkage Projects
  • 资助金额:
    $16.59万
  • 财政年份:
    2014
  • 负责人:
    Prof James De Voss
  • 依托单位:
Understanding the mechanism of two important cytochrome P450 catalysed reactions: dehydrogenation and C-C cleavage
  • 批准号:
    DP140103229
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $23.07万
  • 财政年份:
    2014
  • 负责人:
    Prof James De Voss
  • 依托单位:
Understanding and Inhibiting the P450 CYP24 enzyme, a target for cancer chemotherapeutics.
  • 批准号:
    DP0881116
  • 项目类别:
    Discovery Projects
  • 资助金额:
    $16.99万
  • 财政年份:
    2008
  • 负责人:
    Prof James De Voss
  • 依托单位:
海外基金